Transitions in relabeling personalized medicine as precision medicine, precision health, or wellness genomics reflect shifting the locus of responsibility for health from individuals to clinicians and in shifting focus from genetic risk to genetic enhancement.
AMA J Ethics. 2018;20(9):E881-890. doi:
Today’s international health interventions—like colonial treatment campaigns—can be well-intentioned and still oppress and harm people they try to serve. Grasp of imperial medical history is critical for helping global health professionals understand the contexts in which they practice.
AMA J Ethics. 2016;18(7):743-753. doi:
Since the 1960s, drug names have been products of complex, multiparty negotiations in which interests of patients, pharmaceutical firms, clinicians, and US and international regulators must be balanced.
AMA J Ethics. 2019;21(8):E686-696. doi: